logo

For the Inventor, By the Inventor

Waltham, MA, United States of America

Translate Bio, Inc.


USPTO Granted Patents = 172

% Expired Patents = 0.58



Trademarks = 1

Forward Citations = 584

Loading Chart...
Loading Chart...

69 inventors (with patents filed for the assignee):

goldMedal Michael W Heartlein (138 out of 187 patents)

silverMedal Frank DeRosa (132 out of 146 patents)

bronzeMedal Shrirang Karve (63 out of 68 patents)

4.  Braydon Charles Guild (45 out of 61 patents)

5.  Anusha Dias (38 out of 39 patents)

6.  Frank Derosa (21 out of 25 patents)

7.  Jonathan Abysalh (13 out of 13 patents)

8.  Arthur Mertz Krieg (13 out of 69 patents)

9.  Romesh R Subramanian (12 out of 75 patents)

10.  Zarna Patel (11 out of 14 patents)

11.  Lianne Smith (11 out of 13 patents)

12.  Ashish Sarode (8 out of 11 patents)

13.  Daniel Crawford (8 out of 9 patents)

14.  Yi Zhang (8 out of 8 patents)

15.  Jeannie T Lee (6 out of 28 patents)


Core Competencies:
Messenger RNA
Lipid Nanoparticles
Cationic Lipids
Purification Methods
mRNA Therapy
Nucleic Acids
Codon-Optimized
Biodegradable Lipids
Nanoparticle Formulations
Cystic Fibrosis
Genetic Disorders
Enzyme Modification

172 patents:

1. 12702693 - TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF CODON-OPTIMIZED mRNA ENCODING CFTR (2026-08-11),
2. 12698258 - Cystine cationic lipids (2026-08-04),
3. 12697309 - MRNA-loaded lipid nanoparticles and processes of making the same (2026-08-04),
4. 12697302 - Tricine and citric acid lipids (2026-08-04),
5. 12678406 - Process of preparing ice-based lipid nanoparticles (2026-07-14),
6. 12673086 - Process and formulation of lipid nanoparticles (2026-07-07),
7. 12655095 - TES-based cationic lipids (2026-06-16),
8. 12600998 - Large Scale Synthesis of Messenger RNA (2026-04-14),
9. 12594295 - CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES (2026-04-07),
10. 12594245 - Dry Powder Formulations for Messenger RNA (2026-04-07),
11. 12577600 - MODIFICATION OF RNA-RELATED ENZYMES FOR ENHANCED PRODUCTION (2026-03-17),
12. 12577554 - Methods for Purification of Messenger RNA (2026-03-17),
13. 12576030 - COMPOSITIONS FOR DELIVERY OF CODON-OPTIMIZED MRNA (2026-03-17),
14. 12564645 - METHODS FOR TREATMENT OF METHYLMALONIC ACIDEMIA (2026-03-03),
15. 12553043 - Methods and compositions for messenger RNA purification (2026-02-17),
Translate Bio, Inc. is a clinical-stage mRNA therapeutics company. The company focuses on developing transformative medicines to treat diseases caused by protein or gene dysfunction. With its proprietary mRNA platform, Translate Bio aims to address a broad range of diseases including rare genetic disorders, pulmonary diseases, and oncology. The company's innovative approach utilizes messenger RNA (mRNA) to instruct cells in the body to produce therapeutic proteins with the goal of restoring health and function.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

172 Patents

#11 in Waltham, MA

#128 in Massachusetts

#2,326 in US

#4,808 in the World

Waltham, MA (US)
Waltham, MA, United States of America

Translate Bio, Inc.

Forward Citations = 584

69 inventors:

goldMedal Michael W Heartlein (138 out of 187 patents)

silverMedal Frank DeRosa (132 out of 146 patents)

bronzeMedal Shrirang Karve (63 out of 68 patents)

4.  Braydon Charles Guild (45 out of 61 patents)

5.  Anusha Dias (38 out of 39 patents)

Please report any incorrect information to [email protected]
Loading…